Affiliation:
1. Hematology Division, Department of Medicine, Houston Methodist Hospital, Weill Cornell Medical College, Houston, TX
Abstract
Abstract
Heparin was discovered 100 years ago, and the heparin-induced thrombocytopenia syndrome was described 40 years ago. That the most powerful anticoagulant of the last century can also produce the most extreme prothrombotic diathesis is but one of the paradoxes that surround heparin-induced thrombocytopenia. Standard treatment is alternative anticoagulation. Advances continue to be made regarding pathophysiology, prevention, and treatment. Currently, an epidemic of overdiagnosis threatens the well-being of patients, so efforts to educate clinicians on when and how to make this diagnosis are pressing.
Publisher
American Society of Hematology
Reference48 articles.
1. A clinician’s perspective on heparin-induced thrombocytopenia: Paradoxes, myths and realities;Rice,2007
2. Lessons learned from the contamination of heparin;Liu;Nat Prod Rep,2009
3. Arterial embolism occurring during systemic heparin therapy;Weismann;AMA Arch Surg,1958
4. Heparin—a cause of arterial emboli?;Roberts;Surgery,1964
5. Thrombocytopenia occurring during the administration of heparin: a prospective study in 52 patients;Bell;Ann Intern Med,1976
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献